Jefferies Group LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $579,126 - $1.35 Million	-78,900 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$11.38 - $53.41 $895,606 - $4.2 Million	78,700 New	78,700 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $897,882 - $4.21 Million	78,900 New	78,900 $1.32 Million
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $2.69 Million - $4.18 Million	-99,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $2.2 Million - $3.53 Million	99,000 New	99,000 $3.23 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.02B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.